Sansulin Log-G (insulin glargine biosimilar) / Sanbe  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Sansulin Log-G (insulin glargine biosimilar) / Sanbe
NCT04591457: The Efficacy, Safety, and Immunogenicity Study Comparing an Insulin Glargine Biosimilar Sansulin Log-G to Lantus

Not yet recruiting
2
120
RoW
Insulin Glargine Sansulin, Sansulin, Insulin Glargine Pen Injector [Lantus], Lantus
Indonesia University
Diabetes Mellitus
08/21
08/21

Download Options